Everolimus in patients with advanced pancreatic neuroendocrine tumors (pNET): Updated results of a randomized, double-blind, placebo-controlled, multicenter, phase III trial (RADIANT-3).
2011 ◽
Vol 29
(15_suppl)
◽
pp. 4009-4009
◽
2011 ◽
Vol 106
◽
pp. S59
◽
Keyword(s):
2008 ◽
Vol 26
(15_suppl)
◽
pp. 4507-4507
◽
2001 ◽
Vol 29
(3)
◽
pp. 503-510
◽
2011 ◽
Vol 47
◽
pp. S459
◽